Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Core Laboratories (CLB) Net Income towards Common Stockholders (2022 - 2025)

Core Laboratories' Net Income towards Common Stockholders history spans 4 years, with the latest figure at $6.5 million for Q4 2025.

  • For Q4 2025, Net Income towards Common Stockholders fell 19.48% year-over-year to $6.5 million; the TTM value through Dec 2025 reached $31.8 million, down 2.74%, while the annual FY2025 figure was $31.8 million, 3.01% down from the prior year.
  • Net Income towards Common Stockholders reached $6.5 million in Q4 2025 per CLB's latest filing, down from $14.5 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $22.9 million in Q2 2023 to a low of -$8.6 million in Q4 2023.
  • Average Net Income towards Common Stockholders over 4 years is $7.4 million, with a median of $7.6 million recorded in 2022.
  • The largest YoY upside for Net Income towards Common Stockholders was 220.42% in 2023 against a maximum downside of 243.01% in 2023.
  • A 4-year view of Net Income towards Common Stockholders shows it stood at $6.0 million in 2022, then crashed by 243.01% to -$8.6 million in 2023, then skyrocketed by 193.75% to $8.1 million in 2024, then decreased by 19.48% to $6.5 million in 2025.
  • Per Business Quant, the three most recent readings for CLB's Net Income towards Common Stockholders are $6.5 million (Q4 2025), $14.5 million (Q3 2025), and $10.7 million (Q2 2025).